𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P30 Tissue microarray-based studies of patients with lymph node-negative breast carcinoma show that HER-2/neu overexpression is an important predictive marker of poor prognosis

✍ Scribed by J.H. Ahn; S.B. Kim; G.Y. Gong; M.J. Kim; B.H. Son; S.H. Ahn; S.D. Ahn; S.W. Lee; Y.K. Kang; W.K. Kim

Book ID
114315948
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
58 KB
Volume
16
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue microarray-based studies of patie
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors
✍ Idris Tolgay Ocal; Marisa Dolled-Filhart; Thomas G. D'Aquila; Robert L. Camp; Da 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

## Abstract ## BACKGROUND It has been shown that receptor tyrosine kinases (RTKs) predict outcome in patients with breast carcinoma. Although RTKs are a large family, HER‐2, epidermal growth factor receptor (EGFR), Met (hepatocyte growth factor receptor), and others all have shown the ability to p

Decreased immunoreactivity for p27 prote
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V
✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m